- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7076 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Patent holdings for IPC class A61K 31/7076
Total number of patents in this class: 2056
10-year publication summary
|
167
|
174
|
169
|
156
|
184
|
190
|
211
|
212
|
173
|
45
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 301 |
58 |
| Atea Pharmaceuticals, Inc. | 65 |
37 |
| Epizyme, Inc. | 383 |
34 |
| Can-fite Biopharma Ltd. | 57 |
30 |
| Gilead Sciences, Inc. | 1879 |
25 |
| The Regents of the University of California | 18943 |
24 |
| Chiesi Farmaceutici S.p.A. | 940 |
24 |
| The Board of Regents of the University of Texas System | 2043 |
23 |
| Merck Sharp & Dohme LLC | 3689 |
23 |
| Alios BioPharma, Inc. | 69 |
20 |
| Emory University | 1498 |
18 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
18 |
| University Health Network | 979 |
18 |
| Future Medicine Co., Ltd. | 32 |
17 |
| University of South Florida | 1817 |
16 |
| Pharmacyclics LLC | 240 |
15 |
| Board of Regents, The University of Texas System | 5370 |
13 |
| The Johns Hopkins University | 5377 |
13 |
| Idenix Pharmaceuticals LLC | 66 |
13 |
| University of Virginia Patent Foundation | 1470 |
13 |
| Other owners | 1604 |